DeepMed Research

DANA-FARBER CANCER INSTITUTE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1947-01-01

Employees: -

Market Cap: -

Website: http://www.dana-farber.org/

Clinical Trials

Sleep Treatment Education Program for Cancer Survivors: STEP-Together

Not Applicable

Recruiting

Conditions: Insomnia
Insomnia Chronic
Survivorship

First Posted Date: 2024-12-16

Last Posted Date: 2025-05-07

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 100

Registration Number: NCT06736548

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Integrating Pain-CBT Into an mHealth Analgesic Support Intervention for Patients With Chronic Pain From Advanced Cancers

Not Applicable

Recruiting

Conditions: Pain
Pain Syndrome
Advanced Cancer

First Posted Date: 2024-12-09

Last Posted Date: 2025-05-16

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 60

Registration Number: NCT06722014

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

Not Applicable

Recruiting

Conditions: Lung Cancer
EGFR Gene Mutation

First Posted Date: 2024-12-04

Last Posted Date: 2025-04-17

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 1000

Registration Number: NCT06716580

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute at Steward St. Elizabeth's, Brighton, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

and more 3 locations

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

Not Applicable

Recruiting

Conditions: Ovarian Cancer
Advanced Ovarian Carcinoma
Fallopian Tube Carcinoma
Primary Peritoneal Cancer
PARP Inhibitor
Fatigue Related to Cancer Treatment
Fatigue in Cancer Survivors

First Posted Date: 2024-11-29

Last Posted Date: 2025-04-08

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 240

Registration Number: NCT06710548

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Belzutifan in Recurrent Clear Cell Ovarian Carcinoma

Phase 2

Recruiting

Conditions: Ovarian Cancer
Ovarian Carcinoma

Interventions: Drug: Belzutifan

First Posted Date: 2024-11-06

Last Posted Date: 2025-01-13

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 32

Registration Number: NCT06677190

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision

Early Phase 1

Recruiting

Conditions: Skin Cancer
Cutaneous Squamous Cell Carcinoma (CSCC)
Cutaneous Squamous Cell Cancer

Interventions: Biological: Fluzone Trivalent

First Posted Date: 2024-10-29

Last Posted Date: 2025-01-16

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 25

Registration Number: NCT06664151

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study

Not Applicable

Not yet recruiting

Conditions: Cancer Survivorship

Interventions: Behavioral: Supervised Exercise and Diet Program
Behavioral: Unsupervised Exercise and Diet Program

First Posted Date: 2024-10-02

Last Posted Date: 2025-04-17

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 1528

Registration Number: NCT06623097

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors

Not Applicable

Recruiting

Conditions: Childhood Cancer
Childhood Cancer Survivors

Interventions: Behavioral: CHEF Intervention Program

First Posted Date: 2024-09-24

Last Posted Date: 2025-04-09

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 17

Registration Number: NCT06609473

Locations: 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: the PROPEL Trial

Not Applicable

Recruiting

Conditions: Rectal Cancer
Rectal Cancer Stage III
Rectal Cancer Stage II
Colorectal Cancer

Interventions: Behavioral: Prehabilitation Program

First Posted Date: 2024-08-21

Last Posted Date: 2025-03-11

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 40

Registration Number: NCT06565052

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies

Not Applicable

Withdrawn

Conditions: Myeloid Malignancy
Myeloid Malignancies
Blood Cancers
Blood Cancer

Interventions: Other: Genetic Blood Test

First Posted Date: 2024-08-09

Last Posted Date: 2024-11-22

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 200

Registration Number: NCT06543511

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy